{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T02:19:16Z","timestamp":1768529956246,"version":"3.49.0"},"posted":{"date-parts":[[2025,10,15]]},"group-title":"Biochemistry","reference-count":37,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"funder":[{"name":"National Institute of health","award":["EY34568"],"award-info":[{"award-number":["EY34568"]}]},{"name":"National Institute of health","award":["EY031631"],"award-info":[{"award-number":["EY031631"]}]},{"name":"National Institute of health","award":["GM144927"],"award-info":[{"award-number":["GM144927"]}]},{"name":"National Institute of health","award":["HL007737"],"award-info":[{"award-number":["HL007737"]}]},{"name":"National Institute of health","award":["AI007281"],"award-info":[{"award-number":["AI007281"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,11,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Previous studies have shown the metabolic and regulatory significance of CYP46A1 in the adult retina; however, its role in the developing retina is unknown. Here, we evaluate CYP46A1 expression and the impact of its activation in the developing mouse retina under normal and pathological conditions. Seven-day-old (P7) C57BL\/6J mice maintained in room air (controls) or subjected to oxygen-induced retinopathy (OIR) were treated with\/without 20 mg\/kg efavirenz (EFV), a CYP46A1 activator administered intraperitoneally from P7 to P17. Retinal cross sections and flat mounts were prepared to study retinal vasculature morphology, M\u00fcller and microglia activation, and ganglion cell viability. EFV treatment significantly reduced pathological neovascularization and the size of avascular and hypoxic areas in OIR mice retinas. EFV treatment additionally limited reactive gliosis and microglia activation and improved retinal ganglion cell survival in OIR mice. The current study demonstrates the developmental regulation of CYP46A1 and the dysregulated expression and levels of the downstream metabolite 24-Hydroxycholesterol (24HC) in OIR mice. The study further suggests that pharmacological CYP46A1 activation may improve key pathological features associated with pathological neovascularization in OIR mice.<\/jats:p>","DOI":"10.1101\/2025.10.14.682405","type":"posted-content","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T23:05:11Z","timestamp":1760569511000},"source":"Crossref","is-referenced-by-count":0,"title":["CYP46A1 Activation Improves Retinal Neovascularization in a Mouse Model of Retinopathy of Prematurity"],"prefix":"10.64898","author":[{"given":"Briah","family":"Bailey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine Rudd","family":"Zhong Manis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayatri","family":"Seth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubhra","family":"Rajpurohit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allston","family":"Oxenrider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela M.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravirajsinh N.","family":"Jadeja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menaka C.","family":"Thounaojam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2025111015450555000_2025.10.14.682405v2.1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-011-1610-7"},{"key":"2025111015450555000_2025.10.14.682405v2.2","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12049"},{"issue":"1","key":"2025111015450555000_2025.10.14.682405v2.3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5409\/wjcp.v5.i1.35","article-title":"Retinopathy of prematurity: Past, present and future","volume":"5","year":"2016","journal-title":"World J Clin Pediatr"},{"issue":"7","key":"2025111015450555000_2025.10.14.682405v2.4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","year":"2013","journal-title":"Eye (Lond)"},{"key":"2025111015450555000_2025.10.14.682405v2.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1208129"},{"key":"2025111015450555000_2025.10.14.682405v2.6","doi-asserted-by":"publisher","DOI":"10.3980\/j.issn.2222-3959.2013.02.23"},{"key":"2025111015450555000_2025.10.14.682405v2.7","doi-asserted-by":"publisher","DOI":"10.1007\/BF02044227"},{"key":"2025111015450555000_2025.10.14.682405v2.8","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.84.2.138"},{"key":"2025111015450555000_2025.10.14.682405v2.9","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.80.4.343"},{"key":"2025111015450555000_2025.10.14.682405v2.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(01)00660-1"},{"key":"2025111015450555000_2025.10.14.682405v2.11","doi-asserted-by":"crossref","unstructured":"Thounaojam, M.C. , et al., Ursodeoxycholic Acid Halts Pathological Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy. J Clin Med, 2020. 9(6).","DOI":"10.3390\/jcm9061921"},{"key":"2025111015450555000_2025.10.14.682405v2.12","doi-asserted-by":"crossref","unstructured":"Warden, C. and M.A. Brantley, Jr ., Glycine-Conjugated Bile Acids Protect RPE Tight Junctions against Oxidative Stress and Inhibit Choroidal Endothelial Cell Angiogenesis In Vitro. Biomolecules, 2021. 11(5).","DOI":"10.3390\/biom11050626"},{"key":"2025111015450555000_2025.10.14.682405v2.13","doi-asserted-by":"crossref","unstructured":"Win, A. , et al., Pharmacological and Metabolic Significance of Bile Acids in Retinal Diseases. Biomolecules, 2021. 11(2).","DOI":"10.3390\/biom11020292"},{"key":"2025111015450555000_2025.10.14.682405v2.14","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.116.307558"},{"key":"2025111015450555000_2025.10.14.682405v2.15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ebiom.2016.09.025","article-title":"Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis","volume":"13","year":"2016","journal-title":"EBioMedicine"},{"key":"2025111015450555000_2025.10.14.682405v2.16","doi-asserted-by":"publisher","DOI":"10.1021\/pr1008898"},{"key":"2025111015450555000_2025.10.14.682405v2.17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI63816"},{"key":"2025111015450555000_2025.10.14.682405v2.18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037926"},{"key":"2025111015450555000_2025.10.14.682405v2.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2014.05.024"},{"key":"2025111015450555000_2025.10.14.682405v2.20","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6021"},{"key":"2025111015450555000_2025.10.14.682405v2.21","doi-asserted-by":"publisher","DOI":"10.1038\/383728a0"},{"issue":"8","key":"2025111015450555000_2025.10.14.682405v2.22","first-page":"3029","article-title":"Differential bile acids biosynthetic pathways in the developing retina and in the oxygen-induced model of retinopathy of prematurity","volume":"62","year":"2021","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"61","key":"2025111015450555000_2025.10.14.682405v2.23","doi-asserted-by":"crossref","first-page":"103568","DOI":"10.18632\/oncotarget.21592","article-title":"STAT3-mediated activation of miR-21 is involved in down-regulation of TIMP3 and neovascularization in the ischemic retina","volume":"8","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"2025111015450555000_2025.10.14.682405v2.24","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2025111015450555000_2025.10.14.682405v2.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2014.03.002"},{"key":"2025111015450555000_2025.10.14.682405v2.26","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R010538"},{"key":"2025111015450555000_2025.10.14.682405v2.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2018.10.013"},{"issue":"3","key":"2025111015450555000_2025.10.14.682405v2.28","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s13311-019-00737-0","article-title":"CYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD Mice","volume":"16","year":"2019","journal-title":"Neurotherapeutics"},{"key":"2025111015450555000_2025.10.14.682405v2.29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.723577"},{"issue":"1","key":"2025111015450555000_2025.10.14.682405v2.30","doi-asserted-by":"crossref","first-page":"12837","DOI":"10.1038\/s41598-018-29978-3","article-title":"Efavirenz exposure, alone and in combination with known drugs of abuse, engenders addictive-like bio-behavioural changes in rats","volume":"8","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"2025111015450555000_2025.10.14.682405v2.31","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00109-022-02195-2","article-title":"Neurovascular abnormalities in retinopathy of prematurity and emerging therapies","volume":"100","year":"2022","journal-title":"J Mol Med (Berl)"},{"key":"2025111015450555000_2025.10.14.682405v2.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2006.05.003"},{"key":"2025111015450555000_2025.10.14.682405v2.33","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.01221"},{"key":"2025111015450555000_2025.10.14.682405v2.34","doi-asserted-by":"publisher","DOI":"10.1002\/path.2611"},{"key":"2025111015450555000_2025.10.14.682405v2.35","doi-asserted-by":"publisher","DOI":"10.1002\/cne.23521"},{"key":"2025111015450555000_2025.10.14.682405v2.36","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.05-1522"},{"key":"2025111015450555000_2025.10.14.682405v2.37","doi-asserted-by":"crossref","unstructured":"Zhou, Z. , et al., Distinguished Functions of Microglia in the Two Stages of Oxygen-Induced Retinopathy: A Novel Target in the Treatment of Ischemic Retinopathy. Life (Basel), 2022. 12(10).","DOI":"10.3390\/life12101676"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.10.14.682405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T09:49:27Z","timestamp":1768470567000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.10.14.682405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":37,"URL":"https:\/\/doi.org\/10.1101\/2025.10.14.682405","relation":{},"subject":[],"published":{"date-parts":[[2025,10,15]]},"subtype":"preprint"}}